loading
Scpharmaceuticals Inc stock is traded at $3.35, with a volume of 52,758. It is down -0.74% in the last 24 hours and down -24.55% over the past month. scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
See More
Previous Close:
$3.36
Open:
$3.36
24h Volume:
52,758
Relative Volume:
0.15
Market Cap:
$165.09M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
-2.5188
EPS:
-1.33
Net Cash Flow:
$-60.45M
1W Performance:
-0.74%
1M Performance:
-24.55%
6M Performance:
-12.81%
1Y Performance:
-40.76%
1-Day Range:
Value
$3.28
$3.40
1-Week Range:
Value
$3.075
$3.60
52-Week Range:
Value
$3.075
$6.71

Scpharmaceuticals Inc Stock (SCPH) Company Profile

Name
Name
Scpharmaceuticals Inc
Name
Phone
617-517-0730
Name
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Name
Employee
96
Name
Twitter
@scPharmaUSA
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
SCPH's Discussions on Twitter

Compare SCPH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SCPH 3.34 165.09M 17.63M -57.71M -60.45M -1.33
VRTX 447.18 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.71 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.84 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.36 24.49B 3.30B -501.07M 1.03B 11.54

Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-01-22 Initiated Cowen Outperform
Oct-21-22 Resumed Jefferies Buy
Oct-11-22 Upgrade SVB Leerink Mkt Perform → Outperform
Aug-02-22 Initiated Maxim Group Buy
Sep-09-21 Initiated SVB Leerink Mkt Perform
Oct-15-19 Initiated H.C. Wainwright Buy
Jan-30-19 Downgrade Leerink Partners Outperform → Mkt Perform
View All

Scpharmaceuticals Inc Stock (SCPH) Latest News

pulisher
Nov 19, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St

Nov 19, 2024
pulisher
Nov 18, 2024

Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term - Simply Wall St

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Expects Reduced Earnings for scPharmaceuticals - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

King Luther Capital Management Corp's Strategic Acquisition in scPharmaceuticals Inc - GuruFocus.com

Nov 16, 2024
pulisher
Nov 16, 2024

Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

500: Something went wrong - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

SCPH stock touches 52-week low at $3.24 amid market challenges - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

The one-year earnings decline has likely contributed toscPharmaceuticals' (NASDAQ:SCPH) shareholders losses of 33% over that period - Simply Wall St

Nov 15, 2024
pulisher
Nov 14, 2024

Earnings call: scPharmaceuticals reports robust Q3 growth, eyes FDA nod By Investing.com - Investing.com UK

Nov 14, 2024
pulisher
Nov 14, 2024

ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: R - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

scPharmaceuticals Reports Strong Growth in Q3 2024 - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

ScPharmaceuticals Q3 Loss Widens, Revenue Rises - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

scPharmaceuticals' FUROSCIX Revenue Surges 164% YoY to $10M in Q3, Expands FDA Approval | SCPH Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 10, 2024

Certain Common Stock of scPharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2024. - Marketscreener.com

Nov 10, 2024
pulisher
Nov 07, 2024

scPharmaceuticals (SCPH) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

scPharmaceuticals Sets Q3 2024 Earnings Call for November 13 | SCPH Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 02, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

KING LUTHER CAPITAL MANAGEMENT CORP Expands Stake in scPharmaceu - GuruFocus.com

Nov 01, 2024
pulisher
Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 21, 2024

Third Time's The Charm For ScPharma? - RTTNews

Oct 21, 2024
pulisher
Oct 15, 2024

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

Congestive Heart Failure Treatment Market 2034: Clinical - openPR

Oct 15, 2024
pulisher
Oct 09, 2024

The Attractiveness of Investing In scPharmaceuticals Inc (SCPH) is Growing - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Daily Progress: scPharmaceuticals Inc (SCPH) Drop -2.33, Closing at 3.97 - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

scPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38M - MSN

Oct 08, 2024
pulisher
Oct 07, 2024

Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? - MSN

Oct 07, 2024
pulisher
Oct 05, 2024

351,806 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Acquired by Bank of Montreal Can - MarketBeat

Oct 05, 2024
pulisher
Sep 28, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest Down 15.0% in September - MarketBeat

Sep 28, 2024
pulisher
Sep 23, 2024

Holdings of scPharmaceuticals Inc (SCPH) are aligned with the stars - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Craig Hallum gives a Buy recommendation for scPharmaceuticals Inc (SCPH) - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

King Luther Capital Management Corp Purchases 752,005 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 21, 2024
pulisher
Sep 16, 2024

Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year - Yahoo Finance

Sep 16, 2024
pulisher
Sep 12, 2024

Rice Hall James & Associates LLC Has $2.16 Million Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 12, 2024
pulisher
Sep 11, 2024

scPharmaceuticals Inc [SCPH] Investment Guide: What You Need to Know - Knox Daily

Sep 11, 2024
pulisher
Sep 09, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Stock Holdings Increased by AIGH Capital Management LLC - MarketBeat

Sep 09, 2024
pulisher
Sep 05, 2024

scPharmaceuticals Inc [SCPH] 10% Owner makes an insider purchase of 500,000 shares worth 2.0 million. - Knox Daily

Sep 05, 2024
pulisher
Sep 04, 2024

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 04, 2024

scPharmaceuticals’ $125 Million Senior Secured Term Loan - Global Legal Chronicle

Sep 04, 2024
pulisher
Sep 02, 2024

Do investors need to be concerned about scPharmaceuticals Inc (SCPH)? - US Post News

Sep 02, 2024
pulisher
Sep 02, 2024

There is no way scPharmaceuticals Inc (SCPH) can keep these numbers up - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

scPharmaceuticals Inc (SCPH) rating initates by Craig Hallum - Knox Daily

Sep 02, 2024
pulisher
Aug 25, 2024

Assenagon Asset Management S.A. Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Aug 25, 2024
pulisher
Aug 21, 2024

scPharmaceuticals Inc. to Post Q3 2024 Earnings of ($0.28) Per Share, HC Wainwright Forecasts (NASDAQ:SCPH) - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Craig Hallum’s latest rating for SCPH stock - Knox Daily

Aug 21, 2024

Scpharmaceuticals Inc Stock (SCPH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):